Search Results - "metastasis"
Suggested Topics within your search.
Suggested Topics within your search.
- Neoplasms
- Cancer 8
- therapy 6
- Cancer cells 5
- Cell Transformation, Neoplastic 5
- Epithelial-Mesenchymal Transition 5
- Immunological aspects 5
- Tumors 5
- drug therapy 5
- metabolism 5
- Anti-Inflammatory Agents, Non-Steroidal 3
- Antineoplastic Agents 3
- Antineoplastic agents 3
- Cancer invasiveness 3
- Colorectal Neoplasms 3
- Complications 3
- Computer Simulation 3
- Diagnostic Imaging 3
- Gene Expression Regulation, Neoplastic 3
- Genes, Neoplasm 3
- Genetic aspects 3
- Inflammation 3
- Ketorolac 3
- Macrophages 3
- Medical Oncology 3
- Metastasis 3
- Neoplasm Metastasis 3
- Neoplasm Recurrence, Local 3
- Neoplastic Stem Cells 3
- Neovascularization, Physiologic 3
-
1
Genetics of tumor metastasis part 2 of 2 /
Published 2015Subjects: Get full text
Series
Electronic Video -
2
Genetics of tumor metastasis part 2 of 2 /
Published 2015Subjects: Get full text
Series
Electronic Video -
3
Genetics of tumor metastasis part 2 of 2 /
Published 2015Subjects: Get full text
Series
Electronic Video -
4
How tumor-microenvironment interactions drive or inhibit metastasis
Published 2021Table of Contents: “…Contents: Tumor Organismal Environment (TOE) and Tumor Microenvironment (TME) -- Principles of intra-TME interactions -- Tumor progression and regression -- Site-specific metastasis -- The pre-metastatic niche -- The metastatic cascade -- Epithelial to Mesenchymal Transition (EMT) -- Targeting tumor-TME interactions -- Immune checkpoint blocking enables TME-infiltrating T cells to kill tumor cells.…”
Get full text
Series
Electronic Video -
5
How tumor-microenvironment interactions drive or inhibit metastasis
Published 2021Table of Contents: “…Contents: Tumor Organismal Environment (TOE) and Tumor Microenvironment (TME) -- Principles of intra-TME interactions -- Tumor progression and regression -- Site-specific metastasis -- The pre-metastatic niche -- The metastatic cascade -- Epithelial to Mesenchymal Transition (EMT) -- Targeting tumor-TME interactions -- Immune checkpoint blocking enables TME-infiltrating T cells to kill tumor cells.…”
Get full text
Series
Electronic Video -
6
G proteins and GPCRs in cancer
Published 2019Table of Contents: “…Contents: G proteins and GPCRs as oncogenes -- G proteins and GPCRs in tumorigenesis -- GPCR signalling -- GPCRs and metastasis -- GPCRs and tumor-induced angiogenesis -- GPCR targeting and immunotherapies.…”
Get full text
Series
Electronic Video -
7
G proteins and GPCRs in cancer
Published 2019Table of Contents: “…Contents: G proteins and GPCRs as oncogenes -- G proteins and GPCRs in tumorigenesis -- GPCR signalling -- GPCRs and metastasis -- GPCRs and tumor-induced angiogenesis -- GPCR targeting and immunotherapies.…”
Get full text
Series
Electronic Video -
8
Solution proposed to a 2000 year old problem in oncology
Published 2019Table of Contents: “…Contents: Primary cancer surgery -- Systemic inflammation -- Metastatic amplification -- Perioperative inflammation as triggering origin of metastasis development -- Hazards of relapse -- Computer simulations and clinical observations -- The linkage between wounding, immunology, inflammation and oncology -- Ketorolac and the uses of perioperative NSAIDs.…”
Get full text
Series
Electronic Video -
9
Solution proposed to a 2000 year old problem in oncology
Published 2019Table of Contents: “…Contents: Primary cancer surgery -- Systemic inflammation -- Metastatic amplification -- Perioperative inflammation as triggering origin of metastasis development -- Hazards of relapse -- Computer simulations and clinical observations -- The linkage between wounding, immunology, inflammation and oncology -- Ketorolac and the uses of perioperative NSAIDs.…”
Get full text
Series
Electronic Video -
10
Solution proposed to a 2000 year old problem in oncology
Published 2019Table of Contents: “…Contents: Primary cancer surgery -- Systemic inflammation -- Metastatic amplification -- Perioperative inflammation as triggering origin of metastasis development -- Hazards of relapse -- Computer simulations and clinical observations -- The linkage between wounding, immunology, inflammation and oncology -- Ketorolac and the uses of perioperative NSAIDs.…”
Get full text
Series
Electronic Video -
11
Clinical applications of molecular imaging imaging to guide cancer therapy /
Published 2010Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series
Electronic Video -
12
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
13
Clinical applications of molecular imaging imaging to guide cancer therapy /
Published 2010Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series
Electronic Video -
14
Clinical applications of molecular imaging imaging to guide cancer therapy /
Published 2010Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series
Electronic Video -
15
Tumor-associated macrophages
Published 2012Table of Contents: “…Contents: The correlation between Tumor Associated Macrophage (TAM) infiltration and tumor progression in cancer patients -- Evidence for a protumoral function of TAMs in mouse tumor models -- Hallmark features of TAMs enable tumor progression -- Promotion of inflammation -- Chronic inflammatory diseases and cancer risk -- Promotion of matrix remodeling -- Promotion of tumor cell invasion -- Promotion of metastasis -- Promotion of angiogenesis -- TAM heterogeneity in tumors -- Identification and characterization of TAM subsets in mouse tumor models -- TIE2-expressing macrophages and inflammatory TAMs -- Origins of TAM subsets: Distinct hypothesis -- Tumor responses to anticancer therapies: Role of TAMs -- Reprogramming TAMs from a pro- to an anti-tumoral function -- Deciphering TAM heterogeneity in human cancer -- Complexity of leukocyte infiltrates in human cancer.…”
Get full text
Series
Electronic Video -
16
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
17
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
18
Tumor-associated macrophages
Published 2012Table of Contents: “…Contents: The correlation between Tumor Associated Macrophage (TAM) infiltration and tumor progression in cancer patients -- Evidence for a protumoral function of TAMs in mouse tumor models -- Hallmark features of TAMs enable tumor progression -- Promotion of inflammation -- Chronic inflammatory diseases and cancer risk -- Promotion of matrix remodeling -- Promotion of tumor cell invasion -- Promotion of metastasis -- Promotion of angiogenesis -- TAM heterogeneity in tumors -- Identification and characterization of TAM subsets in mouse tumor models -- TIE2-expressing macrophages and inflammatory TAMs -- Origins of TAM subsets: Distinct hypothesis -- Tumor responses to anticancer therapies: Role of TAMs -- Reprogramming TAMs from a pro- to an anti-tumoral function -- Deciphering TAM heterogeneity in human cancer -- Complexity of leukocyte infiltrates in human cancer.…”
Get full text
Series
Electronic Video -
19
Tumor-associated macrophages
Published 2012Table of Contents: “…Contents: The correlation between Tumor Associated Macrophage (TAM) infiltration and tumor progression in cancer patients -- Evidence for a protumoral function of TAMs in mouse tumor models -- Hallmark features of TAMs enable tumor progression -- Promotion of inflammation -- Chronic inflammatory diseases and cancer risk -- Promotion of matrix remodeling -- Promotion of tumor cell invasion -- Promotion of metastasis -- Promotion of angiogenesis -- TAM heterogeneity in tumors -- Identification and characterization of TAM subsets in mouse tumor models -- TIE2-expressing macrophages and inflammatory TAMs -- Origins of TAM subsets: Distinct hypothesis -- Tumor responses to anticancer therapies: Role of TAMs -- Reprogramming TAMs from a pro- to an anti-tumoral function -- Deciphering TAM heterogeneity in human cancer -- Complexity of leukocyte infiltrates in human cancer.…”
Get full text
Series
Electronic Video